Frontier Medicines
Initial Transaction Details
Transaction Date
April 2019
Purpose of Financing
Venture
Stage of Company
Seed/Startup
Structure of Financing
Equity
Frontier Medicines is a precision medicine company that has pioneered a powerful discovery and development platform designed to generate medicines against disease-causing proteins previously considered undruggable. The company is deploying its technologies in chemoproteomics, covalent drug discovery, and machine learning to potentially develop groundbreaking medicines for genetically-defined patient populations, starting in cancer. Frontier is advancing its wholly-owned pipeline of precision medicines against the most important drivers of cancer.
Website